Search Within

Taha Merghoub

  1. "2017"
Formats
  1. Journal Article (18)
  2. Meeting Abstract (12)
  3. Book Section (1)
Groups
  1. Department of Medicine (31)
  2. Melanoma and Immunotherapeutics Service (31)
  3. Solid Tumor Oncology Division (31)
  4. GSK Faculty (25)
  5. Sloan Kettering Institute Postdocs (18)
  6. Sloan Kettering Institute Faculty (7)

More Groups

People
  1. Jedd Wolchok (21)
  2. Jacob Ricca (6)
  3. Sadna Budhu (6)
  4. Dmitriy Zamarin (5)
  5. Matthew Hellmann (5)
  6. Alexandra Snyder Charen (4)

More People

Years
  1. 2017 (31)
Publications
  1. Journal for ImmunoTherapy of Cancer (11)
  2. Nature (3)
  3. Cancer Immunology Research (2)
  4. Cell (2)
  5. Oncotarget (2)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. Biomed Central Ltd (11)
  2. Nature Publishing Group (4)
  3. American Association for Cancer Research (2)
  4. Cell Press (2)
  5. Impact Journals (2)
  6. AME Publishing Company (1)

More Publishers

Results (31)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Intratumoral delivery of inactivated modified vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-dependent dendritic cells
    Journal Article

    Dai, P.; Wang, W.; Yang, N.; Serna-Tamayo, C.; Ricca, J. M.; Zamarin, D.; Shuman, S.; Merghoub, T.; Wolchok, J. D.; Deng, L.
    Science Immunology (2017)

    Fulltext@MSK | Save
  • PTEN loss-of-function alterations are associated with intrinsic resistance to BRAF inhibitors in metastatic melanoma
    Journal Article

    Catalanotti, F.; Cheng, D. T.; Shoushtari, A. N.; Johnson, D. B.; Panageas, K. S.; Momtaz, P.; Higham, C.; Won, H. H.; Harding, J. J.; Merghoub, T.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • Targeting the IDO/TDO pathway through degradation of the immunosuppressive metabolite kynurenine and inhibition of the downstream AHR pathway
    Meeting Abstract

    McGovern, K.; Zhang, X. M.; Stone, E.; Triplett, T.; Garrison, K.; Coma, S.; Campesato, L. F.; Walsh, M.; Tchaicha, J.; Lamb, C.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Upregulation of PD-L1 in tumor microenvironment is a resistance mechanism for oncolytic virus immunotherapy
    Meeting Abstract

    Zamarin, D.; Ricca, J.; Oseledchyk, A.; Gigoux, M.; Merghoub, T.; Wolchok, J.
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Dissecting the mechanisms underlying antitumor effects of live oncolytic vaccinia and heat-inactivated vaccinia
    Meeting Abstract

    Wang, W.; Dai, P.; Yang, N.; Shuman, S.; Merghoub, T.; Wolchok, J.; Deng, L.
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects
    Meeting Abstract

    Hirschhorn, D.; Ricca, J.; Gasmi, B.; Mangarin, L. M.; De Henau, O.; Budhu, S.; Li, Y.; Cortez, C.; Xia, Y.; Zhong, H.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Isoform specific TGF-β inhibition in combination with radiation therapy as a novel immune therapeutic approach to cancer therapy
    Meeting Abstract

    Gupta, A.; Budhu, S.; Giese, R.; van Snick, J.; Uyttenhove, C.; Ritter, G.; Wolchok, J.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Characterization of the anti-CTLA-4 antibody AGEN1884, including toxicology and pharmacology assessments in non-human primates
    Meeting Abstract

    Gombos, R.; Gonzalez, A.; Manrique, M.; Chand, D.; Savitsky, D.; Morin, B.; Breous-Nystrom, E.; Dupont, C.; Ward, R.; Mundt, C.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • AGEN2034, a novel anti-PD-1 antibody that combines effectively with CTLA-4 pathway blockade to enhance T cell activity
    Meeting Abstract

    Chand, D.; Savitsky, D.; Gonzalez, A.; Clarke, C.; Schuster, A.; Drouin, E. E.; Waight, J. D.; Mundt, C.; Ritter, G.; Merghoub, T.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Phosphatidylserine targeting antibody in combination with tumor radiation and immune checkpoint blockade promotes anti-tumor activity in mouse B16 melanoma
    Meeting Abstract

    Budhu, S.; Giese, R.; De Henau, O.; Zappasodi, R.; Campesato, L. F.; Gupta, A.; Barker, C.; Freimark, B.; Wolchok, J. D.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save